How individual participant data meta-analyses have influenced trial design, conduct, and analysis

Autor: Alderson, P., Askie, L., Bennett, D., Burdett, S., Clarke, M., Dias, S., Emberson, J., Gueyffier, F., Iorio, A., Macleod, M., Mol, B.W., Moons, C., Parmar, M., Perera, R., Phillips, R., Pignon, J.P., Rees, J., Reitsma, H., Riley, R., Rovers, M., Rydzewska, L., Schmid, C., Shepperd, S., Stenning, S., Stewart, L., Tierney, J., Tudur Smith, C., Vale, C., Welge, J., White, I., Whiteley, W., Tierney, Jayne F., Pignon, Jean-Pierre, Gueffyier, Francois, Clarke, Mike, Askie, Lisa, Vale, Claire L., Burdett, Sarah

Publikováno v: In Journal of Clinical Epidemiology November 2015 68(11):1325-1335

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Autor: Nordlinger, B, Sorbye, H, Glimelius, B, Poston, Gj, Schlag, Pm, Rougier, P, Bechstein, Wo, Primrose, Jn, Walpole, Et, FINCH JONES, M, Jaeck, D, Mirza, D, Parks, Rw, Collette, L, Praet, M, Bethe, U, VAN CUTSEM, E, Scheithauer, W, Gruenberger, T, Hohenberger, W, Iveson, T, Karner, J, Levi, J, Hugh, T, DE GREVE, J, Chan, A, Davidson, B, Lindner, P, Peeters, M, Stein, B, Diamond, T, Ducreux, M, Lasser, P, Graeven, U, Paillot, B, Doran, J, Gouillat, C, Iesalnieks, I, Jauch, Kw, JAGOT LACOUSSIERE, P, Jansen, Rl, Koehne, H, Konopke, R, Otto, F, Sherlock, D, VAN HAZEL, G, Ackland, S, Bedenne, L, Bories, E, CLAVERO FABRI MC, Conroy, T, KAMINSKY FORRETT MC, Husseini, F, Karapetis, C, Mãœller, L, Price, T, Rosenberg, R, Schott, J, Tschmelitsch, J, VAN LAETHEM JL, Wals, J, Weimann, A, Arnaud, Jp, Arsene, D, Auby, D, Bhattacharya, S, Cebon, E, Cherqui, D, Confente, C, Dousset, B, Frickhofen, N, Frilling, A, Evan, P, Ganju, V, Hã–ffken, K, Lazorthes, F, Letoublon, C, Madroszyk, A, Nitti, Donato, Orr, B, Pariente, Ea, Pector, Jc, Raoul, Jl, Rees, M, Ridwelski, K, Rouanet, P, Toogood, Gj, Vergauwe, P, Wilke, Hj, Kaplan, R, Horiot, Jc, Littbrand, B, Awada, A, Stenning, S, Lejeune, F.

Publikováno v: Lancet
Lancet, Elsevier, 2008, 371 (9617), pp.1007-1016. ⟨10.1016/S0140-6736(08)60455-9⟩
Nordlinger, B, Sorbye, H, Glimelius, B, Poston, G J, Schlag, P M, Rougier, P, Bechstein, W O, Primrose, J N, Walpole, E T, Finch-Jones, M, Jaeck, D, Mirza, D, Parks, R W, Collette, L, Praet, M, Bethe, U, Van Cutsem, E & Scheithauer, W & Gruenberger, T 2008, ' Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983) : a randomised controlled trial ', The Lancet, vol. 371, no. 9617, pp. 1007-16 . https://doi.org/10.1016/S0140-6736(08)60455-9

Summary Background Surgical resection alone is regarded as the standard of care for patients with liver metastases from colorectal cancer, but relapse is common. We assessed the combination of perioperative chemotherapy and surgery compared with surg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86fb514a5e4c0044302c6b9705dfcad3
https://doi.org/10.1016/s0140-6736(08)60455-9

GCT-10 - Outcomes of adolescent males with extracranial metastatic germ cell tumours compared with children and young adults: A report from the Malignant Germ Cell Tumour International Consortium (MaGIC) group

Autor: Shaikh, F., Stark, D., Dang, H., Xia, C., Krailo, M., Stenning, S., Pashankar, F., Rodriguez-Galindo, C., Olson, T., Depani, S., Stoneham, S., Nicholson, J., Murray, M., Amatruda, J., Billmire, D., Fonseca, A., Lindsay Frazier, A.

Publikováno v: In European Urology Supplements September 2019 18(4):9-9

915P - Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)

Autor: Huddart, R.A., Cafferty, F., White, J., Shamash, J., Hennig, I.M., Cullen, M., Stenning, S.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8

929O_PR - ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis

Autor: Clamp, A.R., McNeish, I., Dean, A., Gallardo, D., Weon-Kim, J., O'Donnell, D., Hook, J., Coyle, C., Blagden, S.P., Brenton, J., Naik, R., Perren, T., Sundar, S., Cook, A., James, E., Swart, A.M., Stenning, S., Kaplan, R., Ledermann, J.

Publikováno v: In Annals of Oncology September 2017 28 Supplement 5:v627-v627